Occidental Announces Dividend
HOUSTON, Feb. 13, 2020 (GLOBE NEWSWIRE) — Occidental Petroleum Corporation (NYSE:OXY) said today that its Board of Directors has declared […]
Enertopia Announces Royalty Sale and Next Steps Forward
KELOWNA, British Columbia, Feb. 13, 2020 (GLOBE NEWSWIRE) — Enertopia Corporation (ENRT) on the OTC (the “Company” or “Enertopia”) is […]
FutureFuel to Release Year-End 2019 Financial Results on March 13, 2020
CLAYTON, MO. , Feb. 13, 2020 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance […]
Integrated Cannabis Company, Inc. Announces Name Change
VANCOUVER, British Columbia, Feb. 13, 2020 (GLOBE NEWSWIRE) — Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Integrated Cannabis” or […]
TC Energy files 2019 annual disclosure documents
CALGARY, Alberta, Feb. 13, 2020 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) has […]
GREENROSE ACQUISITION CORP. ANNOUNCES CLOSING OF $150 MILLION INITIAL PUBLIC OFFERING
Woodbury, NY, Feb. 13, 2020 (GLOBE NEWSWIRE) — Greenrose Acquisition Corp. (Nasdaq: GNRSU) (the “Company”) announced today that it completed […]
Annovis Bio Announces Update on Phase II Clinical Trial for Alzheimer’s Disease
BERWYN, Pa., Feb. 13, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing […]
Consolidated Communications to Present at the J.P. Morgan Global High Yield & Leveraged Finance Conference
MATTOON, Ill., Feb. 13, 2020 (GLOBE NEWSWIRE) — Consolidated Communications Holdings, Inc. (Nasdaq: CNSL), a leading broadband and business communications […]
Atlas Air Worldwide to Report Fourth-Quarter and Full-Year 2019 Results on Thursday, February 20
PURCHASE, N.Y., Feb. 13, 2020 (GLOBE NEWSWIRE) — Atlas Air Worldwide Holdings, Inc. (Nasdaq: AAWW) will release results for the […]
AIM ImmunoTech подает три предварительные заявки на патент использования Ampligen® против схожего с вирусом SARS нового коронавируса Ухань 2019 года
Ampligen® достиг 100% выживаемости при клинически достижимых уровнях дозировки для человека при вирусе SARS в экспериментах на животныхAmpligen – ключ […]
